Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc (NQ: ALLK )

3.020 -0.110 (-3.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 651,723
Open 3.160
Bid (Size) 3.020 (1)
Ask (Size) 3.090 (3)
Prev. Close 3.130
Today's Range 2.920 - 3.230
52wk Range 2.535 - 112.87
Shares Outstanding 54,776,915
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
89 Biggest Movers From Friday
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Allakos
Allakos (NASDAQ:ALLK) has observed the following analyst ratings within the last quarter: 
Via Benzinga

Performance

YTD
-69.22%
-69.22%
1 Month
+8.63%
+8.63%
3 Month
-48.38%
-48.38%
6 Month
-69.15%
-69.15%
1 Year
-96.54%
-96.54%

More News

Read More
Dow Jones Turns Lower; Revlon Shares Jump
Via Benzinga
33 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces Investigation of Breaches of Fiduciary Duties by Management of Allakos Inc.– ALLK
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces Investigation of Breaches of Fiduciary Duties by Management of Allakos Inc.– ALLK
From The Schall Law Firm
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street
Via Benzinga
5 Stocks To Watch For May 9, 2022
Via Benzinga
Recap: Allakos Q1 Earnings
Via Benzinga
Analyst Ratings For Allakos
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
5 Important Investing Lessons From Allakos’ Price Collapse
Via InvestorPlace
Allakos Is a Cautionary Tale of Biopharmaceutical Investing
Via InvestorPlace
After a Clinical-Data Bombshell, Allakos Might Actually Be a Buy
Via InvestorPlace
(ALLK) - Analyzing Allakos Inc's Short Interest
Via Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Via Benzinga
54 Biggest Movers From Thursday
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dow Eyes Third-Straight Pop Ahead of Christmas Break
Via Talk Markets
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
10 Biggest Price Target Changes For Thursday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.